Buda Juice(BUDA.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Buda Juice
BUDA.US
Buda Juice, Inc. engages in producing and distributing UltraFresh juices, lemonades, limeades, and wellness shots. The company offers clean-label beverages that are not pasteurized and contain no preservatives, GMOs, or artificial ingredients. The company provides USDA certified organic, cold-pressed juices made from fruits and vegetables, available in glass bottles with shelf life ranging from eight to twelve days.
1.019 T
BUDA.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    BUDA's (NYSEAMERICAN:BUDA) Quiet Period Set To Expire on February 17th

    Market Beat·
    US
    BUDA
    -1.80%
    Market Beat·
    US
    BUDA
    -1.80%

    Wonder Juice™ introduces two new Wonder Green flavors: Clean Green and Veg8 & Cayenne, expanding its portfolio. #Bayonne #Juice #Innovation

    Unusual Whales·
    US
    JSDA
    +3.32%
    US
    BUDA
    -1.80%
    Unusual Whales·
    US
    JSDA
    +3.32%
    US
    BUDA
    -1.80%

    Buda Juice Announces Full Exercise of Underwriters’ Over-Allotment Option in Connection with Initial Public Offering

    fidelity·
    US
    BUDA
    -1.80%
    fidelity·
    US
    BUDA
    -1.80%

    U.S. stock market midday update: Strong momentum in the IPO market boosts Buda Juice's stock price by 11.17%

    Tracking Unusual Activity·
    US
    BUDA
    -1.80%
    Tracking Unusual Activity·
    US
    BUDA
    -1.80%

    US IPO Weekly Recap: Aktis Oncology leads as first sizable 2026 IPO

    RenaissanceCapital·
    US
    BUDA
    -1.80%
    RenaissanceCapital·
    US
    BUDA
    -1.80%
    © 2026 Longbridge｜Disclaimer